Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.
Authors: Goldin LR,  Lanasa MC,  Slager SL,  Cerhan JR,  Vachon CM,  Strom SS,  Camp NJ,  Spector LG,  Leis JF,  Morrison VA,  Glenn M,  Rabe KG,  Achenbach SJ,  Algood SD,  Abbasi F,  Fontaine L,  Yau M,  Rassenti LZ,  Kay NE,  Call TG,  Hanson CA,  Weinberg JB,  Marti GE,  Caporaso NE
Journal: Br J Haematol
Date: 2010 Oct
Branches: ITEB
PubMed ID: 20738309
PMC ID: PMC2966536
Abstract: Monoclonal B-cell lymphocytosis (MBL) is an asymptomatic haematological condition characterized by low absolute levels of B-cell clones with a surface immunophenotype similar to that of chronic lymphocytic leukaemia (CLL). In the general population, MBL increases with age with a prevalence of 5-9% in individuals over age 60 years. It has been reported to be higher among first-degree relatives from CLL families. We report results of multi-parameter flow cytometry among 505 first-degree relatives with no personal history of lymphoproliferative disease from 140 families having at least two cases of CLL. Seventeen percent of relatives had MBL. Age was the most important determinant where the probability for developing MBL by age 90 years was 61%. MBL clustered in certain families but clustering was independent of the number of known CLL cases in a family. As is the case with CLL, males had a significantly higher risk for MBL than did females (P = 004). MBL patients had significantly higher mean absolute lymphocyte counts (24 10(9) /l) and B-cell counts (053 10(9) /l) than those with a normal B-cell immuno-phenotype. Our findings show that MBL occurs at a very high rate in high risk CLL families. Both the age and gender distribution of MBL are parallel to CLL, implying a shared inherited risk.